{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jin SH"],"funding":["National Institutes of Health(NIH)","National Research Foundation of Korea(NRF)","NIAMS NIH HHS"],"pagination":["356-361"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6089868"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["51(7)"],"pubmed_abstract":["Actin-binding LIM protein 1 (ABLIM1), a member of the LIM-domain protein family, mediates interactions between actin filaments and cytoplasmic targets. However, the role of ABLIM1 in osteoclast and bone metabolism has not been reported. In the present study, we investigated the role of ABLIM1 in the receptor activator of NF-κB ligand (RANKL)- mediated osteoclastogenesis. ABLIM1 expression was induced by RANKL treatment and knockdown of ABLIM1 by retrovirus infection containing Ablim1-specific short hairpin RNA (shAblim1) decreased mature osteoclast formation and bone resorption activity in a RANKL-dose dependent manner. Coincident with the downregulated expression of osteoclast differentiation marker genes, the expression levels of c-Fos and the nuclear factor of activated T-cells cytoplas"],"journal":["BMB reports"],"pubmed_title":["Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility."],"pmcid":["PMC6089868"],"funding_grant_id":["AR069546","R01 AR067726","NRF-2011-0030130","AR067726","NRF-2016R1D1A1B03932658","R01 AR069546"],"pubmed_authors":["Park KH","Lee YR","Kim H","Jin SH","Lee SH","Choi Y","Gu DR"],"additional_accession":[]},"is_claimable":false,"name":"Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility.","description":"Actin-binding LIM protein 1 (ABLIM1), a member of the LIM-domain protein family, mediates interactions between actin filaments and cytoplasmic targets. However, the role of ABLIM1 in osteoclast and bone metabolism has not been reported. In the present study, we investigated the role of ABLIM1 in the receptor activator of NF-κB ligand (RANKL)- mediated osteoclastogenesis. ABLIM1 expression was induced by RANKL treatment and knockdown of ABLIM1 by retrovirus infection containing Ablim1-specific short hairpin RNA (shAblim1) decreased mature osteoclast formation and bone resorption activity in a RANKL-dose dependent manner. Coincident with the downregulated expression of osteoclast differentiation marker genes, the expression levels of c-Fos and the nuclear factor of activated T-cells cytoplas","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Jul","modification":"2025-04-21T14:56:49.64Z","creation":"2019-03-26T23:52:13Z"},"accession":"S-EPMC6089868","cross_references":{"pubmed":["29921413"],"doi":["10.5483/bmbrep.2018.51.7.106"]}}